Copyright Reports & Markets. All rights reserved.

Global and China Biopharmaceutical Contract Manufacturing(BCMO) Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Mammalian Based Manufacturing
    • 1.2.3 Microbial Based Manufacturing
    • 1.2.4 Other
  • 1.3 Market by Application
    • 1.3.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Application: 2020 VS 2026
    • 1.3.2 Bio-Pharmaceutical Companies
    • 1.3.3 Pharmaceutical Companies
    • 1.3.4 Drug Discovery Companies
    • 1.3.5 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Perspective (2015-2026)
  • 2.2 Global Biopharmaceutical Contract Manufacturing(BCMO) Growth Trends by Regions
    • 2.2.1 Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Biopharmaceutical Contract Manufacturing(BCMO) Historic Market Share by Regions (2015-2020)
    • 2.2.3 Biopharmaceutical Contract Manufacturing(BCMO) Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Biopharmaceutical Contract Manufacturing(BCMO) Players by Market Size
    • 3.1.1 Global Top Biopharmaceutical Contract Manufacturing(BCMO) Players by Revenue (2015-2020)
    • 3.1.2 Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Players (2015-2020)
  • 3.2 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Biopharmaceutical Contract Manufacturing(BCMO) Revenue
  • 3.4 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Concentration Ratio
    • 3.4.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical Contract Manufacturing(BCMO) Revenue in 2019
  • 3.5 Key Players Biopharmaceutical Contract Manufacturing(BCMO) Area Served
  • 3.6 Key Players Biopharmaceutical Contract Manufacturing(BCMO) Product Solution and Service
  • 3.7 Date of Enter into Biopharmaceutical Contract Manufacturing(BCMO) Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Biopharmaceutical Contract Manufacturing(BCMO) Breakdown Data by Type (2015-2026)

  • 4.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Historic Market Size by Type (2015-2020)
  • 4.2 Global Biopharmaceutical Contract Manufacturing(BCMO) Forecasted Market Size by Type (2021-2026)

5 Biopharmaceutical Contract Manufacturing(BCMO) Breakdown Data by Application (2015-2026)

  • 5.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Historic Market Size by Application (2015-2020)
  • 5.2 Global Biopharmaceutical Contract Manufacturing(BCMO) Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size (2015-2026)
  • 6.2 North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2015-2020)
  • 6.3 North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2015-2020)
  • 6.4 North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size (2015-2026)
  • 7.2 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2015-2020)
  • 7.3 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2015-2020)
  • 7.4 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Biopharmaceutical Contract Manufacturing(BCMO) Market Size (2015-2026)
  • 8.2 China Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2015-2020)
  • 8.3 China Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2015-2020)
  • 8.4 China Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Biopharmaceutical Contract Manufacturing(BCMO) Market Size (2015-2026)
  • 9.2 Japan Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2015-2020)
  • 9.3 Japan Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2015-2020)
  • 9.4 Japan Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Biopharmaceutical Contract Manufacturing(BCMO) Market Size (2015-2026)
  • 10.2 Southeast Asia Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Lonza Group Ltd
    • 11.1.1 Lonza Group Ltd Company Details
    • 11.1.2 Lonza Group Ltd Business Overview
    • 11.1.3 Lonza Group Ltd Biopharmaceutical Contract Manufacturing(BCMO) Introduction
    • 11.1.4 Lonza Group Ltd Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2015-2020))
    • 11.1.5 Lonza Group Ltd Recent Development
  • 11.2 Boehringher Ingelheim
    • 11.2.1 Boehringher Ingelheim Company Details
    • 11.2.2 Boehringher Ingelheim Business Overview
    • 11.2.3 Boehringher Ingelheim Biopharmaceutical Contract Manufacturing(BCMO) Introduction
    • 11.2.4 Boehringher Ingelheim Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2015-2020)
    • 11.2.5 Boehringher Ingelheim Recent Development
  • 11.3 Sandoz
    • 11.3.1 Sandoz Company Details
    • 11.3.2 Sandoz Business Overview
    • 11.3.3 Sandoz Biopharmaceutical Contract Manufacturing(BCMO) Introduction
    • 11.3.4 Sandoz Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2015-2020)
    • 11.3.5 Sandoz Recent Development
  • 11.4 Fujifilm Diosynth Biotechnology
    • 11.4.1 Fujifilm Diosynth Biotechnology Company Details
    • 11.4.2 Fujifilm Diosynth Biotechnology Business Overview
    • 11.4.3 Fujifilm Diosynth Biotechnology Biopharmaceutical Contract Manufacturing(BCMO) Introduction
    • 11.4.4 Fujifilm Diosynth Biotechnology Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2015-2020)
    • 11.4.5 Fujifilm Diosynth Biotechnology Recent Development
  • 11.5 Rentschler Biotechnologie
    • 11.5.1 Rentschler Biotechnologie Company Details
    • 11.5.2 Rentschler Biotechnologie Business Overview
    • 11.5.3 Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing(BCMO) Introduction
    • 11.5.4 Rentschler Biotechnologie Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2015-2020)
    • 11.5.5 Rentschler Biotechnologie Recent Development
  • 11.6 Celonic GmbH
    • 11.6.1 Celonic GmbH Company Details
    • 11.6.2 Celonic GmbH Business Overview
    • 11.6.3 Celonic GmbH Biopharmaceutical Contract Manufacturing(BCMO) Introduction
    • 11.6.4 Celonic GmbH Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2015-2020)
    • 11.6.5 Celonic GmbH Recent Development
  • 11.7 BIOMEVA GmbH
    • 11.7.1 BIOMEVA GmbH Company Details
    • 11.7.2 BIOMEVA GmbH Business Overview
    • 11.7.3 BIOMEVA GmbH Biopharmaceutical Contract Manufacturing(BCMO) Introduction
    • 11.7.4 BIOMEVA GmbH Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2015-2020)
    • 11.7.5 BIOMEVA GmbH Recent Development
  • 11.8 ProBioGen AG
    • 11.8.1 ProBioGen AG Company Details
    • 11.8.2 ProBioGen AG Business Overview
    • 11.8.3 ProBioGen AG Biopharmaceutical Contract Manufacturing(BCMO) Introduction
    • 11.8.4 ProBioGen AG Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2015-2020)
    • 11.8.5 ProBioGen AG Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Biopharmaceutical Contract Manufacturing(BCMO) Scope and Market Size
    Biopharmaceutical Contract Manufacturing(BCMO) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biopharmaceutical Contract Manufacturing(BCMO) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Mammalian Based Manufacturing
    Microbial Based Manufacturing
    Other

    Market segment by Application, split into
    Bio-Pharmaceutical Companies
    Pharmaceutical Companies
    Drug Discovery Companies
    Other

    Based on regional and country-level analysis, the Biopharmaceutical Contract Manufacturing(BCMO) market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Biopharmaceutical Contract Manufacturing(BCMO) market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Lonza Group Ltd
    Boehringher Ingelheim
    Sandoz
    Fujifilm Diosynth Biotechnology
    Rentschler Biotechnologie
    Celonic GmbH
    BIOMEVA GmbH
    ProBioGen AG

    Buy now